Tyler Shultz, the whistleblower who exposed the fraudulent practices of Theranos, has issued a caution about the current AI boom. Drawing on his experience with Theranos, a healthcare startup that reached a $10 billion valuation despite faulty technology, Shultz warns that the rapid rise of AI companies—many yet to turn a profit—creates fertile ground for deception. He highlights how easy it can be to raise vast sums of money based on hype rather than substance, comparing the pattern to how Theranos raised hundreds of millions by exploiting investor trust.

Shultz underscores the difficulty investors face in performing due diligence on AI technologies, noting that it’s challenging to distinguish genuinely innovative AI solutions from merely repackaged or superficial offerings like so-called "ChatGPT wrappers." This opacity and complexity in AI development make the sector vulnerable to dishonest founders and companies. For Shultz, the record of Theranos serves as a grim reminder that unchecked hype can lead to severe consequences, both financially and ethically, especially when patients’ health or user trust is at stake.

The former Theranos insider also reflects on the recent documentary “You Can See Everything,” which explores Elizabeth Holmes’ manipulation tactics during Theranos’s downfall. While the film refrains from painting Holmes strictly as a villain or victim, Shultz points out that her narrative continues to divert attention away from the broader systemic issues allowing such frauds to flourish. He expresses unease about Holmes’s ongoing influence in tech and warns that she may be preparing a new venture, dubbed "Theranos 2.0," which has already raised about $20 million, indicating her potential continued impact on the startup ecosystem.

Ultimately, Shultz calls for more skepticism and scrupulous scrutiny from investors and the tech community during this AI surge. He believes that without rigorous checks, the AI space could become a playground for those intending to exploit both capital markets and public trust. His insights stress the importance of learning from past mistakes like Theranos, encouraging vigilance to prevent history from repeating itself with newer technologies.